Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis

Current Opinion in Lipidology

Volumn 22, Issue 5, 2011, Pages 373-379

  Kyaw, Tin ^a   Tipping, Peter ^b   Toh, Ban Hock ^b   Bobik, Alex ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

atherosclerosis; B cells; immunity; inflammation

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; ATACICEPT; BELIMUMAB; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LYMPHOCYTE SURFACE MARKER; RITUXIMAB;

ADVENTITIA; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CARDIOVASCULAR RISK; CELL ACTIVATION; CELL EXPANSION; CELL FUNCTION; CELL SELECTION; CELL SURVIVAL; DISEASE COURSE; HUMAN; INTIMA; MOLECULARLY TARGETED THERAPY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TARGET CELL;

ANIMALS; ATHEROSCLEROSIS; B-LYMPHOCYTE SUBSETS; CONNECTIVE TISSUE; HUMANS; INFLAMMATION; TUNICA INTIMA;

MURINAE;

EID: 80052737713     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e32834adaf3     Document Type: Review

References (55)

1. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008; 8:802-815.
2. Ait-Oufella H, Herbin O, Bouaziz JD, et al. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 2010; 207:1579-1587.
3. Kyaw T, Tay C, Khan A, et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 2010; 185:4410-4419.
4. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis (+). Annu Rev Immunol 2009; 27:165-197.
5. Song L, Leung C, Schindler C. Lymphocytes are important in early atherosclerosis. J Clin Invest 2001; 108:251-259. (Pubitemid 32656249)
6. Dansky HM, Charlton SA, Harper MM, Smith JD. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 1997; 94:4642-4646. (Pubitemid 27194296)
7. Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002; 109:745-753. (Pubitemid 34263151)
8. Major AS, Fazio S, Linton MF. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 2002; 22:1892-1898. (Pubitemid 35315778)
9. Nilsson J, Hansson GK, Shah PK. Immunomodulation of atherosclerosis: implications for vaccine development. Arterioscler Thromb Vasc Biol 2005; 25:18-28. (Pubitemid 40054250)
10. Lewis MJ, Malik TH, Ehrenstein MR, et al. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2009; 120:417-426.
11. Winer DA, Winer S, Shen L, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011; 17:610-617.
12. Hamel K, Doodes P, Cao Y, et al. Suppression of proteoglycan-induced arthritis by anti-CD20 B Cell depletion therapy is mediated by reduction in autoantibodies and CD4\+ T cell reactivity. J Immunol 2008; 180:4994-5003.
13. Yanaba K, Hamaguchi Y, Venturi GM, et al. B cell depletion delays collageninduced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity. J Immunol 2007; 179:1369-1380.
14. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol 2001; 19:595-621. (Pubitemid 32368047)
15. LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood 2008; 112:1570-1580.
16. Martin F, Kearney JF. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol Rev 2000; 175:70-79. (Pubitemid 30427157)
17. Yoshida T, Mei H, Dorner T, et al. Memory B and memory plasma cells. Immunol Rev 2010; 237:117-139.
18. Steiniger B, Timphus EM, Barth PJ. The splenic marginal zone in humans and rodents: an enigmatic compartment and its inhabitants. Histochem Cell Biol 2006; 126:641-648. (Pubitemid 44899708)
19. Bende RJ, van Maldegem F, van Noesel CJ. Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas. Haematologica 2009; 94:1109-1123.
20. Viau M, Longo NS, Lipsky PE, Zouali M. Staphylococcal protein a deletes B-1a and marginal zone B lymphocytes expressing human immunoglobulins: an immune evasion mechanism. J Immunol 2005; 175:7719-7727. (Pubitemid 41713472)
21. DiLillo DJ, Hamaguchi Y, Ueda Y, et al. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. J Immunol 2008; 180:361-371.
22. Binder CJ. Natural IgM antibodies against oxidation-specific epitopes. J Clin Immunol 2010; 30 (Suppl 1):S56-60.
23. Almeida SR, Aroeira LS, Frymuller E, et al. Mouse B-1 cell-derived mononuclear phagocyte, a novel cellular component of acute nonspecific inflammatory exudate. Int Immunol 2001; 13:1193-1201. (Pubitemid 32903909)
24. Oliveira HC, Popi AF, Bachi AL, et al. B-1 cells modulate the kinetics of wound-healing process in mice. Immunobiology 2010; 215:215-222.
25. Mauri C, Ehrenstein MR. The 'short' history of regulatory B cells. Trends Immunol 2008; 29:34-40.
26. Sugimoto K, Ogawa A, Shimomura Y, et al. Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation. Gastroenterology 2007; 133:124-136. (Pubitemid 47031122)
27. Tian J, Zekzer D, Hanssen L, et al. Lipopolysaccharide-activated B cells downregulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 2001; 167:1081-1089. (Pubitemid 32660868)
28. Fillatreau S, Sweenie CH, McGeachy MJ, et al. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002; 3:944-950. (Pubitemid 35154008)
29. Lundy SK. Killer B lymphocytes: the evidence and the potential. Inflamm Res 2009; 58:345-357.
30. Harris DP, Haynes L, Sayles PC, et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000; 1:475-482.
31. Galkina E, Kadl A, Sanders J, et al. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med 2006; 203:1273-1282. (Pubitemid 43736596)
32. Moos MP, John N, Grabner R, et al. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005; 25:2386-2391. (Pubitemid 41552659)
33. Zhao L, Moos MP, Grabner R, et al. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med 2004; 10:966-973. (Pubitemid 39273738)
34. Higuchi ML, Gutierrez PS, Bezerra HG, et al. Comparison between adventitial and intimal inflammation of ruptured and nonruptured atherosclerotic plaques in human coronary arteries. Arq Bras Cardiol 2002; 79:20-24.
35. Grabner R, Lotzer K, Dopping S, et al. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/-mice. J Exp Med 2009; 206:233-248.
36. Thaunat O, Patey N, Morelon E, et al. Lymphoid neogenesis in chronic rejection: the murderer is in the house. Curr Opin Immunol 2006; 18:576-579. (Pubitemid 44311452)
37. Surmi BK, Hasty AH. The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue. Vascul Pharmacol 2010; 52:27-36.
38. Link A, Hardie DL, Favre S, et al. Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans. Am J Pathol 2010; 178:1662-1675.
39. Maiellaro K, Taylor WR. The role of the adventitia in vascular inflammation. Cardiovasc Res 2007; 75:640-648. (Pubitemid 47238746)
40. Mayadas TN, Tsokos GC, Tsuboi N. Mechanisms of immune complexmediated neutrophil recruitment and tissue injury. Circulation 2009; 120:2012-2024.
41. Rotzius P, Thams S, Soehnlein O, et al. Distinct infiltration of neutrophils in lesion shoulders in ApoE-/-mice. Am J Pathol 2010; 177:493-500.
42. Drechsler M, Megens RT, van Zandvoort M, et al. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 2010; 122:1837-1845.
43. Allan LL, Hoefl K, Zheng DJ, et al. Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells. Blood 2009; 114:2411-2416.
44. Allan LL, Stax AM, Zheng DJ, et al. CD1d and CD1c expression in human B cells is regulated by activation and retinoic acid receptor signaling. J Immunol 2011; 186:5261-5272.
45. Leadbetter EA, Brigl M, Illarionov P, et al. NK T cells provide lipid antigenspecific cognate help for B cells. Proc Natl Acad Sci USA 2008; 105:8339-8344. (Pubitemid 351904757)
46. Kohchi K, Takebayashi S, Hiroki T, Nobuyoshi M. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation 1985; 71:709-716. (Pubitemid 15099120)
47. Moreno PR, Purushothaman KR, Fuster V, O'Connor WN. Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation 2002; 105:2504-2511. (Pubitemid 34568972)
48. Michel JB, Virmani R, Arbustini E, Pasterkamp G. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J 2011. [Epub ahead of print]. doi: 10.1093/eurheartj/ehr054
49. Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006; 37:1923-1932. (Pubitemid 44297753)
50. Yang EY, Nambi V, Tang Z, et al. Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol 2009; 54:2388-2395.
51. Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2002; 2:465-475. (Pubitemid 37328738)
52. Rauch M, Tussiwand R, Bosco N, Rolink AG. Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells. PLoS One 2009; 4:e5456.
53. Davidson A. Targeting BAFF in autoimmunity. Curr Opin Immunol 2010; 22:732-739.
54. Navarra SV, Guzman RM, Gallacher AE, et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 2011; 377:721-731.
55. Schreiber TH, Wolf D, Tsai MS, et al. Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation. J Clin Invest 2010; 120:3629-3640.